The a-galactose-specific lectin which is found in the rabbit hepatocytes as an integral membrane glycoprotein is involved in the clearance of galactose-terminated glycoproteins (Ashwell & Morell, 1977) . The rabbit liver lectin was isolated and purified by affinity chromatography on columns of Sepharose-asialo-orosomucoid (Hudgin et al., 1974) . It was isolated as a highly aggregated water-soluble material containing 10% sugar by weight. In Triton X-100, aggregation of purified protein was reversed with formation of a single component with an estimated M, of 2.5 x lo5 and composed of subunits with apparent M, of 48000 and 40000 (Kawasaki & Ashwell, 1976) . The purified carbohydrate-binding protein agglutinates human or rabbit erythrocytes and thus can be designated as a lectin. Although originally identified as a galactose-binding protein, methyl-N-acetyl-a-D-galactosaminide has a higher affinity (Sarkar ef al., 1979) . Among a group of synthetic neoglycoproteins the glucosyl derivative binds at least as well as the galactosyl derivative (Stowell & Lee, 1978) . The lectin is specific for asialoglycoproteins and the binding activity was assayed by the formation of a precipitate complex with 1251-asialo-orosomucoid.
Lectins are similar to enzymes in that they exhibit a specific interaction with particular molecules, but are by definition restricted to interactions with sugars. The carbohydrate-binding site(s) of a lectin contains amino acids with side chains that contribute to the association of specific saccharide groups with that lectin, in a manner similar to an enzyme-substrate association.
Chemical modification of active-site amino acid side chains will alter their properties and bring about a change in the biological activity of the lectin. This change in activity can be measured for a variety of modifications of different amino acid side chains, and thus an idea of those involved in the biological activity can be obtained.
We attempted chemical modification of amino acid side chains which may alter the biological activity of this lectin. All the treatments were performed under mild conditions and with reagents that had a high specificity for particular amino acid side chains. The effect on the binding activity of the modified protein was tested by the binding assay using 1 2 5 1 -a~i a l o -o r~~~m u c~i d . The extent of modification was studied either spectrophotometrically or by amino acid analysis.
Amino groups were modified by citraconic anhydride, histidyl groups by ethoxyformic anhydride and arginyl groups by cyclohexane-I ,2-dione. The carboxy groups were modified by carbodi-imide activation in the presence of a-aminobutyric acid methyl ester which led to the incorporation of ester residues. Although modification of the above groups was demonstrated, they do not greatly effect the binding activity of the lectin. It is possible that these effects are due to charge differences which may result in conformational changes in the molecule. Modification of tyrosine residues with tetranitromethane led to an appreciable loss of binding activity. Similarly when tryphophyl groups were modified with 2-hydroxy-5-nitrobenzyl bromide there was also a considerable loss of activity. Modification repeated in the presence of lactose showed that this hapten has only a partial protective effect against the modifying agents. It is possible that although lactose protects some of the residues involved in binding it is not protecting the whole binding region. It is suggested from the results that tyrosyl and tryptophyl groups are essentially involved in the binding site of the lectin. Lysine, histidine, arginine, glutamate and aspartate are not involved in the binding site but their charged groups are important for a fully active conformation. Tolbutamide, a sulphonylurea derivative used clinically t o induce insulin release, interferes with organification of iodine in the thyroid, causing hypothyroidism in 3% of 200 diabetics studied (Portioli & Rocchi, 1969) . Aminoglutethimide (AG) exerts similar, but more potent, effects (Hunter et al., 1965; Hughes & Burley, 1970) . AG also blocks steroid biosynthesis at several points by binding to various cytochromes P-450 (Lyne et al., 1971; Cower, 1974) . Thus, if tolbutamide similarly inhibited thyroid peroxidase, could it also block cytochrome(s) P-450 and alter steroidogenesis in a similar way to AG? Earlier work (Lyne & Cower, 1977) showed that steroids can be nietab- Testes were obtained by castration from 6-week-old Landrace piglets and microsomes were prepared (Cooke & Cower, 1977) . Some of the microsomes were used immediately while the remainder was stored at -20°C so that effects on enzymic activities could be found. Substrates were [4-14C]testosterone or 19-hydroxy [6,7-3H] -(N)-androst-4-ene-3,17-dione (0.25-0.5 yCi/tube) and 0.05 MTris/HCl (pH 7.4) was used to dilute 1001.11 aliquots of microsomal suspensions in 0.25 M-sucrose, making a reaction volume of 500yl; the protein content was 200yg in each tube. AG was added as solid or as phosphate in solution. Tolbutamide was made up from dissolved pills, 613th MEETING, CARDIFF 125 mg/lO ml of distilled water, and additions of 50, 100 or 150pg were made. Incubations, in the presence or the absence of NADPH, AG or tolbutamide, were performed for 20min at 32°C in a shaking water-bath. After the addition of appropriate carrier steroids, extraction of metabolites and t.1.c. were performed (Ayling er al., 1984) .
Testosterone was actively converted to 4-androstenedione, even in the presence of NADPH, with smaller quantities of 19-hydroxy-4-androstenedione also being found.
Freezing of microsomes at -20°C had little inhibitory effect. Only traces of oestrone were formed, presumably because of the massive conversion to 4-androstenedione. In contrast, high yields of oestrone were obtained from 19-hydroxy-4-androstenedione as substrate (cf. Ayling er al., 1984) , and the aromatase system involved was active for at least 9 months at -20°C. The formation of 50-dihydrotestosterone from testosterone (detected as in Watkins & Gower, 1985) decreased by 60% of control values using microsomes that had been stored for 9 days at -2O"C, and was attenuated by 21 days.
Using fresh microsomes with testosterone or 19-hydroxy-4-androstenedione, AG caused complete inhibition of NADPH-and cytochrome P-450-dependent reactions, such as aromatization and hydroxylations, including those possibly at C-7 and C-16 (see Fig. 1 , polar metabolite area).
Using stored (9 months) microsomes, the 4-ene-5a-reductase activity had already been lost and AG caused an 80% diminution in 4-adrostenedione formation from testosterone. The formation of 19-hydroxy-4-androstenedione was completely abolished.
With fresh microsomes, tolbutamide at low doses showed minor inhibitory effects on oestrone formation from testosterone, but at 150pg marked inhibition was noted and also selective deletions of possibly 7-and 16-hydroxylated metabolites. In stored microsomes, there was a doserelated inhibition of 17/Ehydroxysteroid dehydrogenase activity (approx. 60% decrease at 15Opg). However, 19-hydroxy-4-androstendione was not formed, presumably due to the diminution of 4-androstenedione production. With 19-hydroxy-4-androstendione as substrate, tolbutamide (50pg) caused little, if any, change in oestrone production in some experiments (Fig. l) , but we sometimes found paradoxically high formation of oestrone. Occasionally, similar effects were noted with testosterone metabolism in the presence of 50pg of the drug. This possible drug stimulation is inexplicable at present but, in this context, it is of interest that SU 10'603, another steroid hydroxylase inhibitor, has shown paradoxical stimulation of e.p.r. spectral changes in thyroid microsomes which would lead to enhanced steroid metabolism via cytochrome P-450 (C. Lyne & D. Williams-Smith, unpublished work) . In this study, tolubtamide generally seems to be more selective than AG in its binding but similar to the SU series of drugs. The relative potency of tolbutamide and AG against thyroid peroxidase iodination appears to parallel their effects on steroid metabolism.
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